Home › Osteoarthritis › NCT07231471
Platelet Rich Plasma for Musculoskeletal Conditions
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * 18+ years old * Musculoskeletal pathology that may benefit from a PRP injection * Failed other conservative treatments Exclusion Criteria: * No active malignancy * No active infection in the area of injection * No platelet disorder * No active systemic infections * No patients currently undergoing dialysis
About the study
The primary purpose of this study is to follow patients with various musculoskeletal (MSK) conditions over a one-year follow-up period after receiving a platelet rich plasma (PRP) injection, assessing changes in their pain levels, functional abilities, and overall patient satisfaction.
This will develop a robust registry of patients treated with PRP for a range of MSK conditions. These conditions include, but are not limited to, osteoarthritis (OA) of the knee, hip, glenohumeral joint, elbow, ankle, and sacroiliac joint, as well as rotator cuff tendinopathy, lateral and medial epicondylitis, plantar fasciitis, patellar tendinopathy, Achilles tendinopathy, and proximal hamstring tendinopathy.
What is being tested
- Platelet Rich Plasma Injection (biological)
- Platelet Rich Plasma Preparation (device)
Sponsor: University of Utah · Participants: 10,000 · Started: Dec 29, 2025
Contact the study team
- Christina Geisler, MS · Phone: 18012133379
Official record on ClinicalTrials.gov — NCT07231471
Locations in the U.S.
| Utah | University of Utah Orthoaedic Center, Salt Lake City |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.